Boehringer Ingelheim· @Boehringer · X·· 2025-12-20精选AI 评分62
AI 导读
勃林格殷格翰宣布，其新药已获美国FDA批准，用于治疗成人进展性肺纤维化（PPF）。公司称该批准为这一危及生命的疾病患者带来希望，更多信息见 https://go.boehringer.com/SYRTX。
推荐理由
原文给出FDA批准该药用于成人进展性肺纤维化这一事实，读者可据此了解该适应症的监管进展。
正文
#NEWS: The @US_FDA has approved our new treatment for progressive pulmonary fibrosis (PPF) in adults. The approval provides hope to people living with this life-threatening condition.
Learn more here: https://go.boehringer.com/SYRTX
#LifeForward #PulmonaryFibrosis
来源：Boehringer Ingelheim · x.com